SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma

NIL

Jahr

Publikationsjahr
2024

Autoren

Autorenliste der Publikation
Al Rahbani GK, Woopen C, Dunsche M, Proschmann U, Ziemssen T, Akgün K.

Verlag

Publisher-Information
Vaccines. 2024; 12(6):684.

Link

Zur Publikation (externer Server)
https://doi.org/10.3390/vaccines12060684

Tags

Forschungsthemen
Multiple SkleroseNeuroimmunologie
MSZNIL2024